文献速递重症综合管理与镇静镇痛消化、代谢与肾脏急症

高乳酸血症、乳酸动力学与局部枸橼酸抗凝连续肾脏替代治疗中枸橼酸蓄积的预测

Hyperlactatemia, Lactate Kinetics and Prediction of Citrate Accumulation in Critically Ill Patients Undergoing Continuous Renal Replacement Therapy With Regional Citrate Anticoagulation.
PubMed 文献 · Crit Care Med · 2017-01-01
一句话结论在局部枸橼酸抗凝的连续静脉-静脉血液透析中,枸橼酸蓄积风险低(2.26%),初始乳酸浓度预测价值有限,乳酸动力学(12小时乳酸清除率≤24.3%)预测价值更高。

该回顾性随访分析纳入1,070例接受局部枸橼酸抗凝连续静脉-静脉血液透析的急性肾损伤成人患者,研究初始乳酸浓度和乳酸动力学对枸橼酸蓄积的预测价值。治疗前48小时内枸橼酸蓄积发生率为2.26%。初始乳酸正常(<2.2 mmol/L)、升高(≥2.2至<4 mmol/L)和严重高乳酸血症(≥4 mmol/L)患者中枸橼酸蓄积发生率分别为0.77%、2.70%和6.33%。初始乳酸预测枸橼酸蓄积的ROC曲线下面积为0.789,最佳截断值2.39 mmol/L的阴性预测值为99.28%,阳性预测值仅5.21%。枸橼酸蓄积患者48小时乳酸动力学斜率截距为正值且显著高于无蓄积患者(+0.2 vs -0.006 mmol/L/hr,p<0.001)。在初始严重高乳酸血症(≥4 mmol/L)患者中,无蓄积组6、12、18小时乳酸清除率中位数分别为24.0%、48.1%、59.4%,各时间点均显著高于蓄积组(分别为-9.8%、-20.5%、2.3%,各时间点p<0.001)。12小时乳酸清除率预测枸橼酸蓄积的ROC曲线下面积最高(0.839,95%CI 0.751-0.927),最佳截断值24.3%。

要点

  • 局部枸橼酸抗凝连续静脉-静脉血液透析期间枸橼酸蓄积总体发生率低(2.26%),即使初始严重高乳酸血症(≥4 mmol/L)也仅6.33%。
  • 初始乳酸预测枸橼酸蓄积的ROC曲线下面积0.789,最佳截断值2.39 mmol/L时阴性预测值99.28%、阳性预测值仅5.21%。
  • 枸橼酸蓄积患者48小时乳酸动力学斜率截距为+0.2 mmol/L/hr,显著高于无蓄积患者的-0.006 mmol/L/hr(p<0.001)。
  • 初始严重高乳酸血症(≥4 mmol/L)患者中,无蓄积组12小时乳酸清除率中位数48.1%,显著高于蓄积组的-20.5%(p<0.001)。
  • 12小时乳酸清除率预测枸橼酸蓄积的ROC曲线下面积0.839(95%CI 0.751-0.927),最佳截断值24.3%,优于初始乳酸浓度。

适用人群与场景

  • 在大学医院混合内科-外科ICU中,3年期间所有接受局部枸橼酸抗凝连续静脉-静脉血液透析治疗的急性肾损伤成人患者(n=1,070)。
  • 回顾性筛选枸橼酸蓄积的代谢征象。

诊断标准与关键阈值

  • 初始乳酸分组:正常(<2.2 mmol/L)、升高(≥2.2至<4 mmol/L)、严重高乳酸血症(≥4 mmol/L)。
  • 初始乳酸预测枸橼酸蓄积的最佳截断值为2.39 mmol/L。
  • 12小时乳酸清除率预测枸橼酸蓄积的最佳截断值为24.3%。

研究设计与关键结果

  • 研究设计:回顾性随访分析,来自危重症患者队列,单中心(大学医院混合内科-外科ICU),纳入1,070例急性肾损伤成人患者接受局部枸橼酸抗凝连续静脉-静脉血液透析。
  • 主要结果:治疗前48小时内枸橼酸蓄积发生率为2.26%。
  • 初始乳酸正常(<2.2 mmol/L)、升高(≥2.2至<4 mmol/L)、严重高乳酸血症(≥4 mmol/L)患者中枸橼酸蓄积发生率分别为0.77%、2.70%、6.33%。
  • 初始乳酸预测枸橼酸蓄积的ROC曲线下面积0.789;最佳截断值2.39 mmol/L时阴性预测值99.28%,阳性预测值5.21%。
  • 枸橼酸蓄积患者48小时乳酸动力学斜率截距为+0.2 mmol/L/hr,无蓄积患者为-0.006 mmol/L/hr,差异显著(p<0.001)。
  • 初始严重高乳酸血症(≥4 mmol/L)患者中,无蓄积组6、12、18小时乳酸清除率中位数分别为24.0%、48.1%、59.4%,蓄积组分别为-9.8%、-20.5%、2.3%,各时间点差异均显著(p<0.001)。
  • 12小时乳酸清除率预测枸橼酸蓄积的ROC曲线下面积最高(0.839,95%CI 0.751-0.927),最佳截断值24.3%。

证据类型、等级与局限

  • 证据类型:回顾性随访分析。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,在评估枸橼酸蓄积风险时,应考虑乳酸动力学而非初始乳酸浓度升高。
  • 即使初始严重高乳酸血症(≥4 mmol/L),局部枸橼酸抗凝期间枸橼酸蓄积风险仍低(6.33%)。
  • 初始乳酸浓度阴性预测值高(99.28%)但阳性预测值低(5.21%),不宜单独用于识别枸橼酸蓄积。
  • 12小时乳酸清除率≤24.3%可能提示枸橼酸蓄积风险,其ROC曲线下面积0.839(95%CI 0.751-0.927)。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

OBJECTIVES: Citrate accumulation is a major complication of regional citrate anticoagulation during continuous renal replacement therapy. We studied the prediction of citrate accumulation during continuous veno-venous hemodialysis with regional citrate anticoagulation by initial lactate concentrations and lactate kinetics.

DESIGN: A retrospective follow-up analysis from a cohort of critically ill patients.

SETTING: Mixed medical-surgical ICUs at a university hospital.

PATIENTS: All adult patients with acute kidney injury and treated with regional citrate anticoagulation-continuous veno-venous hemodialysis during a 3-year period (n = 1,070) were included in this retrospective study and screened for metabolic signs of citrate accumulation.

INTERVENTIONS: None.

MEASUREMENTS AND MAIN RESULTS: The frequency of citrate accumulation during the first 48 hours of therapy was 2.26%. In patients with initial normal lactate (< 2.2 mmol/L), elevated lactate (≥ 2.2 to < 4 mmol/L), or severe hyperlactatemia (≥ 4 mmol/L), the frequency of citrate accumulation was 0.77%, 2.70%, and 6.33%, respectively. Receiver operating characteristics-area under the curve of initial lactate concentration was 0.789 for the prediction of citrate accumulation. Optimal cutoff from receiver operating characteristics (2.39 mmol/L) showed strong negative prediction (99.28%), but weak positive prediction (5.21%). The slope intercept of lactate kinetics over 48 hours was positive and significantly higher in patients with citrate accumulation compared to those without (+0.2 vs -0.006 mmol/L/hr; p < 0.001). In patients with initial severe hyperlactatemia (≥ 4 mmol/L), the median calculated lactate clearance at 6, 12, and 18 hours was 24.0%, 48.1%, and 59.4% in the nonaccumulation group. These clearance rates were significantly higher at each time-point compared to patients with citrate accumulation (-9.8%, -20.5%, and 2.3%, respectively; p < 0.001 for each time-point). The highest receiver operating characteristics-area under the curve for citrate accumulation was observed for 12-hour values of lactate clearance (area under the curve = 0.839; 95% CI, 0.751-0.927) with an optimal cut-off value of 24.3%.

CONCLUSIONS: Risk of citrate accumulation during regional citrate anticoagulation in a well-selected cohort of patients is low even in case of initial severe hyperlactatemia. Lactate kinetics rather than initially elevated lactate concentration should be considered in assessing the risk of citrate accumulation.

来源:Crit Care Med,查看原文。版权归原作者所有。

参考来源

  1. Khadzhynov D, Dahlinger A, Schelter C, et al. Hyperlactatemia, Lactate Kinetics and Prediction of Citrate Accumulation in Critically Ill Patients Undergoing Continuous Renal Replacement Therapy With Regional Citrate Anticoagulation. Crit Care Med. 2017. PMID: 28538441. doi:10.1097/CCM.0000000000002501

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。